# Faze Medicines: Research, Cambridge, United States

> Faze Medicines: Faze Medicines was a biotechnology company based in Cambridge, Massachusetts, founded in 2020. Based in Cambridge, United States. Founded 2020.

Source: https://millionrounds.com/startup/faze-medicines (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# Faze Medicines

Faze Medicines was a biotechnology company based in Cambridge, Massachusetts, founded in 2020.

Funding reported Last round: Series A

Research Cambridge, United States

Company summary

- **Founded:** 2020 6 years old
- **Team:** 3 1 to 10 people
- **Funding reported:** $81M in dollars
- **Last round:** Series A Dec 2020

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Faze Medicines has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Faze Medicines

Faze Medicines was a biotechnology company based in Cambridge, Massachusetts, founded in 2020.

The company focused on developing therapeutics based on biomolecular condensates, which are clusters of proteins and nucleic acids that play a role in cellular functions. Faze was established by prominent scientists in the field and received significant funding from Third Rock Ventures and other investors. The company aimed to create treatments for neurodegenerative diseases and other conditions with high unmet needs, including Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), and various cancers. Faze Medicines operated in the B2B space within the Life Sciences market, targeting partnerships with the pharmaceutical industry and investors. Faze Medicines ceased operations in November 2022, less than two years after its launch, despite initial funding of $81 million.

## What company datasets say Faze Medicines raised

Funding, as reported

Reported in all **$81M** in dollars

Rounds **1**

Last round **Series A**

Last round size **$81M**

Last round date **Dec 2020**

Investors listed **8**

SEC Form D **$30M sold, 1 filing, last Dec 2020**

## Founders and team

From the SEC filings it signed: 2 on the team.

- **Cary Pfeffer** Executive Officer, Director i
- **Ed Freedman** Executive Officer, Director i

On the board, as filed i *Charles Homcy* *Robert Tepper*

## The company, in detail

What they build

Known for

biotechnology research

Built with from their website

CloudFlare CloudFlare CDN Cloudflare DNS

- **Sector:** Research
- **Region:** Massachusetts
- **Revenue:** $2.5M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/faze-medicines)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put Faze Medicines in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)